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a  b  s  t  r  a  c  t
The  biogenic  amine  histamine  is  an important  neurotransmitter  in  the  central  nervous  system  that  has
been implicated  in learning  and memory  processes.  Experimental  evidence  indicates  that  the  role  of  the
cerebellum  may  be  more  complex  than  the  simple  regulation  of motor  responses,  and  recent  studies
have  demonstrated  signiﬁcant  involvement  of  the  cerebellum  in  emotional  memory  consolidation.  This
study  investigated  the  effect  of  histamine  microinjected  into  the  cerebellar  vermis  on emotional  memory
consolidation  in  mice in  the  elevated  plus-maze  (EPM).  The  cerebellar  vermis  of  male  mice  (Swiss  Albino)
were  implanted  with  guide  cannulae.  The  mice  weighed  between  25  and  30 g. After  three  days  of  recovery,
behavioral  tests  in  the  EPM  were  performed  on  two consecutive  days;  the  testing  periods  were  called,
Trial  1 and  Trial  2. Immediately  after  Trial  1, the  animals  received  microinjections  of histamine  in the
cerebellar  vermis  (0.54,  1.36,  2.72,  and  4.07  nmol/0.1  l).  On  both  days,  the  test  sessions  were recorded
to  enable  analysis  of behavioral  measures.  The  decrease  in  open  arm  exploration  (% entries  and  % time
spent  in the  open  arms)  in Trial  2  relative  to  Trial  1  was  used  as  a measure  of  learning  and  memory.  The
data  were  analyzed  using  One-way  Analysis  of  Variance  (ANOVA)  and  Duncan’s  tests.  The  percentage
of  open  arm  entries  (%OAE)  and  the  percentage  of  time  spent  in  the  open  arms  (%OAT)  were  reduced  in
Trial  2 relative  to  Trial  1  for the  control  group;  the same  was  true  for  the  group  that  was  microinjected
with  histamine  at doses  of  0.54  (%OAE  and  %OAT)  and  1.36  nmol  (%OAT).  However,  when  the  animals
received  histamine  at doses  of  2.72  and  4.07  nmol,  their  open  arm  exploration  did  not decrease.  No
signiﬁcant  changes  were  observed  in  the  number  of  enclosed  arm  entries  (EAE),  an  EPM  index  of  general
exploratory  activity.  These  results  suggest  that  there  is  a dose-dependent  inhibitory  effect of  histamine
microinjected  into  the  cerebellar  vermis  on  emotional  memory  consolidation.. Introduction
Histamine is a biogenic amine and an important
eurotransmitter–neuromodulator in the central nervous system
CNS) [13,22]. Recent evidence has clearly established that his-
amine and its receptors are involved in learning and memory.
umerous experiments using different learning models and
Abbreviations: CNS, central nervous system; EPM, elevated plus-maze; OAE,
pen arm entries; OAT, open arm time; %OAE, percentage of open arm entries; %OAT,
ercentage of open arm time; EAE, enclosed arm entries; EAT, enclosed arm time;
EAT, percentage of enclosed arm time; CT, central area time; SAP, stretched-attend
ostures.
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species suggest that histamine may  be important for several stages
of memory formation and memory retrieval during different tasks,
and they emphasize the role of histamine in the physiological
mechanisms of memory [1,2,23,24,39].  However, these studies
have used many different behavioral tasks and produced con-
tradictory results; for instance, both facilitatory and inhibitory
effects of neuronal histamine on learning and memory have been
described in animal behavior studies [1,6,15,36,46].  The mecha-
nisms underlying these differences seem to be very complex, and
the differences may  be due in part to the methods used and the
approaches selected in the experiments [19].
The central histaminergic nervous system originates from the
tuberomammillary nucleus of the hypothalamus, and in many
Open access under the Elsevier OA license.species, it widely innervates almost the whole brain including the
cerebellum and other subcortical motor structures [38]. Previous
studies have shown that the histamine-containing ﬁbers project
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he deep cerebellar nucleus and that the highest density of his-
aminergic terminations is in the vermis and ﬂocculus [21,45]. A
oderately dense network of histamine ﬁbers has been seen in the
olecular and granular layers of the cerebellum in several species
ncluding humans [14]. These ﬁbers run parallel to the Purkinje
ell layer after traversing it perpendicularly. Both Purkinje cells
nd neurons in the nucleus interpositus have H2 receptors [37],
nd granule cells are excited through both H1 and H2 receptor
ctivation [43].
The cerebellum has traditionally been considered an important
ubcortical motor structure, but several lines of evidence support
he view that the role of the cerebellum is more complex than pre-
iously thought and includes more than just the regulation of motor
esponses [34]. An increasing number of studies have demonstrated
ts involvement in cognitive and emotional function [35]. Func-
ional neuroimaging studies and studies of patients with cerebellar
esions have been conducted to elucidate the role of the cerebellum
n the processing of emotion [35,42,44].  According to Sacchetti et al.
32], the fact that there is a functional interconnection between the
erebellar vermis and the hypothalamus, amygdala, and hippocam-
us suggests that the cerebellum may  play a role in an integrated
etwork regulating emotional behavior. Moreover, Ruediger et al.
29] demonstrated that fear conditioning learning is speciﬁcally
orrelated with the growth of feedforward inhibition connectivity
n hippocampal and cerebellar circuits.
Experimental evidence indicates that the cerebellum plays a
ole in emotional learning. The capacity to learn and retain fear-
onditioned responses was investigated in hotfoot mutant mice.
hese animals are characterized by a primary deﬁciency in the
ynapses made by the parallel ﬁbers onto the Purkinje cells. In these
utant mice, the cerebellar dysfunction impairs learning, which
uggests that these synapses are involved in fear memory consoli-
ation [31]. Studies have related the cerebellar vermis to emotional
emory consolidation. In one study, vermis inactivation caused
mnesic effects after a fear conditioning task [30]. Thus, the par-
icipation of the vermis in emotional memory is independent of its
ole in sensory or motor processes, and the vermis may  represent
n interface between sensory stimuli, emotional state, and motor
esponses [30,34].
Studies have demonstrated the relationship between the
istaminergic system and the cerebellum. Shen et al. [37] demon-
trated that histamine excites the cerebellar interpositus nucleus
ells via the histamine H2 receptor mechanism. They suggested
hat the hypothalamocerebellar histaminergic ﬁbers may  modu-
ate neuronal activity in the cerebellum. The results of a study by
ian et al. [43], revealed that histamine excites cerebellar Purkinje
ells via H2 receptors and that the histaminergic ﬁbers may  play an
mportant role in functional aspects of the cerebellum. In spite of
hese investigations, there have been no reports on the cerebellar
istaminergic system and learning and memory processes.
The elevated plus-maze (EPM) is an animal model test of anxiety
ased on rodents’ natural aversion to open spaces [18]. A general
spect of EPM exploration is that animals enter and spend less time
xploring the open arms [7].  The inclusion of a retest session has
een made in recent years, which is consistent with the assump-
ion that there is a learned component underlying the exploratory
ehavior during EPM re-exposure [8]. According to File et al. [8],
fter the initial exploration of the apparatus, rodents acquire, con-
olidate and retrieve some kind of memory related to exploration of
otentially dangerous areas of the maze. Bertoglio and Carobrez [4]
se Trial 1/2 protocol to show that after a single prior non-drugged
xperience in the maze, mice exhibit signiﬁcantly reduced open
rm activity in a second trial. An increase in open arm avoidance
ith repeated maze exposure has been observed in several studies
7,10,16] and has been used as a measure of learning and memory
12,16,36].ch Bulletin 86 (2011) 134– 138 135
The present study was designed in view of these ﬁndings to
investigate the action of histamine microinjected into the cerebel-
lar vermis on emotional memory consolidation in mice using Trial
1/2 protocol in the EPM.
2. Material and methods
2.1. Animals
Male Swiss mice (Federal University of São Carlos, UFSCar, SP, Brazil) weighing
25–35 g at the beginning of the experiments were housed in polypropylene cages
(31  ×20 × 13 cm)  in groups of ﬁve and maintained under a 12 h light cycle (lights
on  at 7:00 a.m.), in a controlled environment at temperature 23 ± 1 ◦C and humidity
50  ± 5%. Food and drinking water were provided ad libitum,  except during the brief
test periods. All mice were experimentally naive, and the experimental sessions
were conducted during the light period of the cycle (9:00–13:00 h).
2.2. Drugs
Histamine dihydrochloride (Sigma Chemical Co., USA) was prepared in a vehicle
of  physiological saline. Saline solution was  used as an experimental control. The
doses of histamine were based on previous research [28] and on pilot work in our
own  laboratory. The substances were coded, and the codes were unknown to the
experimenter during the tests and behavioral analysis.
2.3.  Surgery and microinjection
Each mouse was  implanted with a single 7 mm stainless steel guide cannula (25
gauge) under ketamine chloridrate and xylazine solution anesthesia (100 mg/kg and
10  mg/kg, respectively, delivered via i.p. injection). The stereotaxic coordinates for
the cerebellar vermis were 6.5 mm posterior to bregma, 0 mm lateral to the midline,
and  2.0 mm ventral to skull surface [9]. The guide cannula was  ﬁxed to the skull
using dental acrylic and Jeweler’s screws. A dummy cannula (33 gauge stainless
steel wire) was inserted into the guide cannula at the time of surgery and served
to  reduce the incidence of occlusion. Postoperative analgesia was provided for 3
days by adding acetaminophen (200 mg/ml) to the drinking water in a ratio of 0.2 ml
acetaminophen to 250 ml water (i.e., the ﬁnal concentration was 0.16 mg/ml). Saline
and  drug solutions were infused into the cerebellar vermis using a microinjection
unit (33 gauge cannula; Cooper’s Needleworks, Birmingham, UK), which extended
2.0  mm beyond the tip of the guide cannula. The microinjection unit was attached
to  a 5 l Hamilton microsyringe via polyethylene tubing (PE-10), and the adminis-
tration was controlled by an infusion pump (Insight Equipamentos Cientíﬁcos Ltda,
Brazil) programmed to deliver a volume of 0.1 l over a period of 60 s. The microin-
jection procedure consisted of gently restraining the animal, inserting the injection
unit, infusing the solution, and keeping the injection needle in situ for a further 60 s
to  avoid reﬂux. Conﬁrmation of successful infusion was  obtained by monitoring the
movement of a small air bubble inside the PE-10 tubing.
2.4. Apparatus
The EPM used was similar to that originally described by Lister et al. [18].
The EPM consisted of two open arms (30 × 5 × 0.25 cm) and two enclosed arms
(30  × 5 × 15 cm)  connected to a common central platform (5 × 5 cm). The appara-
tus was made of crystal acrylic and was raised to a height of 38.5 cm above ﬂoor
level. All tests were conducted under moderate illumination (77 lx) as measured on
the central platform of the EPM and in an environment isolated from the rest of the
room by a black protective curtain.
2.5. Experimental procedure
Three days after surgery, the animals were transported to the experimental
room and left undisturbed for at least 1 h before testing to facilitate adaptation.
The  test was performed on two consecutive days, and the trials in the EPM were
denoted: Trial 1 and Trial 2. Mice were individually placed on the central platform
of  the maze facing the open arm and were able to explore the maze for 5 min. In Trial
1,  immediately after the exposure to the EPM, animals received microinjection of
saline or histamine in the cerebellar vermis (0.54, 1.36, 2.72 and 4.07 nmol/0.1 l).
Twenty-four hours later (Trial 2), mice were re-exposed to the EPM under the same
experimental conditions, but they did not receive any injection. Between subjects,
the  maze was thoroughly cleaned with 5% ethanol and a dry cloth.
2.6. Behavioral analysis
All sessions were video recorded by a digital camera linked to a computer in
an  adjacent room. Images were analyzed by a highly trained observer using X-
PLO-RAT, an ethological analysis pack developed at the Laboratory of Exploratory
Behavior USP/Ribeirao Preto [11]. Behavioral parameters were deﬁned in a way
that was  consistent with previous studies [18,26] and included the following:
the frequency of open- and enclosed-arm entries (OAE and EAE) (an entry was
deﬁned as the entry of all four of an animal’s paws into an arm) and total time
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Table  1
One-way ANOVA statistical results for the behavior of mice with no pharmacological
treatment in Trial 1.
Behavioral measures F p
OAE 0.72 0.55
%OAE 0.34 0.80
OAT  0.99 0.41
%OAT 0.99 0.41

















































Fig. 1. Schematic representation (adapted from Franklin and Paxinos [9]) of sites of
microinfusion into the cerebellums of mice. The number of points is smaller than
the total number of mice because of overlaps.SAP  1.79 0.14
Head dipping 0.71 0.55
Immobility time 0.64 0.60
pent in the open arms (OAT), enclosed arms (EAT), and central area (CT). These
ata were used to calculate the percentage of open arm entries (%OAE = (open
ntries/open + enclosed entries) ×100); the percentage of time spent in the open
rms (%OAT = (open time/300) × 100); and the percentage of time spent in the
nclosed arms (%EAT = (enclosed time/300) × 100). The number of stretched-attend
ostures (SAP; exploratory posture in which the body stretches forward and then
etracts to its original position without any forward locomotion), immobility time
stillness but some movement of the chest), and the frequency of head dipping
exploratory movement of head/shoulders over the sides of the maze) were also
cored. Total SAP was considered a primary index of risk assessment and head
ipping was  considered an index of exploratory behavior [27].
.7. Histology
At the end of testing, all animals received a 0.1 l infusion of 1% methylene blue
ccording to the microinjection procedure described above. The animals received
n  anesthetic overdose, their brains were removed and injection sites were veriﬁed
istologically according to the atlas of Franklin and Paxinos [9]. Data from animals
ith injection sites outside the cerebellar vermis were excluded from the study. The
nal sample size of each cohort ranged between 11 and 16. Histology conﬁrmed that
 total of 70 mice had accurate cannula placements in the cerebellar dorsal vermis
Fig.  1) and that the sample sizes of the different dosage cohorts were as follows:
aline (n = 11), 0.54 nmol histamine (n = 15), 1.36 nmol histamine (n = 15), 2.72 nmol
istamine (n = 16) and 4.07 nmol histamine (n = 13).
.8. Statistical analysis
All results were initially submitted to Levene’s test for homogeneity of variance.
he data were analyzed using a One-way Analysis of Variance (ANOVA) test. When
ifferences were indicated by signiﬁcant F values, they were identiﬁed by Duncan’s
ultiple range tests. A p value of <0.05 was  required for signiﬁcance.
.9. Ethics
The experiments carried out as part of this study were approved by the Animal
thics Commission of the Federal University of Sao Carlos (CEEA 049/09), and they
re  in compliance with the norms of the Brazilian Neuroscience and Behavior Society
SBNeC), which are based on the US National Institutes of Health Guide for Care and
se of Laboratory Animals.
. Results
One-way ANOVA tests showed no signiﬁcant differences
etween groups in Trial 1 for all the measures analyzed (Table 1).
herefore, the data were pooled because the animals had received
o pharmacological treatment at that point. Fig. 2 illustrates the
ffects of microinjection of histamine on %OAE in the ﬁrst and sec-
nd sessions. The ANOVA test showed differences between trials
F5,134 = 4.72, p = 0.0005). The post hoc Duncan’s test indicated that
he mice that entered less often into the open arms in Trial 2 in
omparison with Trial 1 were microinjected with saline (p = 0.001)
nd histamine at a dose of 0.54 nmol (p = 0.02). Moreover, the anal-
sis showed a signiﬁcant difference between the groups that had
eceived saline and histamine at the dose of 4.07 nmol (p = 0.007).Fig. 3 shows the %OAT for the ﬁrst and second sessions. ANOVA
nalysis detected differences between sessions (F5,134 = 6.17,
 = 0.000036) in %OAT. Post hoc analysis revealed that animals
xplored the open arms for a shorter time in the second trial
Fig. 2. Effects of microinjection of histamine (0.54, 1.36, 2.72 and 4.07 nmol) on
the percentage of open arm entries (%OAE) in Trials 1 and 2 in the EPM. Data are
presented as mean ± SEM. n = 11–16. *p < 0.05 Trial 2 versus Trial 1; #p < 0.05 versus
control (saline) in Trial 2.
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vercentage of open arm time (%OAT) in Trials 1 and 2 in the EPM. Data are presented
s  mean ± SEM. n = 11–16. *p < 0.05 Trial 2 versus Trial 1.
hen they had been microinjected with saline (p < 0.001), his-
amine at a dose of 0.54 nmol (p = 0.005), and histamine at a dose
f 1.36 nmol (p = 0.01). For the groups that received histamine at
oses of 2.72 nmol (%OAE: p = 0.16; %OAT: p = 0.09) and 4.07 nmol
%OAE: p = 0.52; %OAT p = 0.10), there were no differences between
rials in both measures.
Table 2 shows the results for all other behaviors. ANOVA anal-
sis did not indicate differences in EAE (F5,134 = 0.61, p = 0.11).
he treatment did not change the locomotor activity. ANOVA
nalysis revealed signiﬁcant differences between trials in OAT
F5,134 = 8.2, p = 0.000001). Post hoc comparisons indicated that
his difference was present for the groups microinjected with
aline (p < 0.001), histamine at a dose of 0.54 nmol (p = 0.002), and
istamine at a dose of 1.36 nmol (p < 0.001). There were also dif-
erences between sessions in the EAT (F5,134 = 9.41, p < 0.00001),
EAT (F5,134 = 9.41, p < 0.00001), CT (F5,134 = 5.85, p = 0.000063), and
requency of head dipping (F5,134 = 10.39, p < 0.00001). ANOVA anal-
sis did not detect any signiﬁcant differences between trials in OAE
F5,134 = 1.86, p = 0.11), immobility time (F5,134 = 1.56, p = 0.18), or
otal SAP (F5,134 = 1.13, p = 0.34).
. Discussion
The main experimental ﬁnding of this study is that the microin-
ection of histamine into the cerebellar vermis impairs emotional
emory consolidation in mice re-exposed to the EPM because open
rm exploration did not decrease in the second session. In addi-
ion, the results indicate that there is a dose-dependent effect of
istamine on the inhibition of memory.
The EPM is a test that assesses behavior associated with emotion
ecause the behavior exhibited during the test arises from a con-
able 2
ffects of microinjection of histamine (0.54, 1.36, 2.72 and 4.07 nmol) on the behavior of 
Pool Saline HA 0.54 
OAE 8.2 ± 0.4 6.6 ± 1.4 6.3 ± 0.9
OAT  119.0 ± 6.9 49.3 ± 9.9* 62.0 ± 9.6
EAE  8.5 ± 0.5 13.9 ± 1.35 11.1 ± 1.1
EAT  89.9 ± 5.3 178.3 ± 53.7* 166.2 ± 14
%EAT 29.6 ±  1.8 59.4 ± 7.9* 53.4 ± 5.7
CT 91.6 ± 0.5 72.4 ± 21.8 71.8 ± 7.5
SAP  9.3 ± 0.0 6.9 ± 1.1 7.9 ± 1.1
HD  5.9 ± 0.9 0.5 ± 0.1* 1.7 ± 0.6
Immobility time 0.0 ± 0.1 0.0 ± 0.0 0.1 ± 0.1
ool (animals exposed to EPM with no pharmacological treatment); Saline (microinjecte
 doses of 0.54 nmol; 1.36 nmol; 2.72 nmol and 4.07 nmol/0.1 l); OAE (number of open
ntries); EAT (time spent in the enclosed arms); %EAT (percentage of time in enclosed ar
frequency of head dipping), immobility time. Data are presented as mean values (±SEM
ersus  control (saline).ch Bulletin 86 (2011) 134– 138 137
ﬂict between the motivation to explore the maze and the natural
tendency to avoid open spaces [4,18].  The EPM is one of the most
widely used behavioral tests in research on anxiety [5,25]. Recently,
it has become useful for understanding the biological basis of emo-
tion related to learning and memory [3,16,41]. During the EPM test,
the animal acquires information about safe and dangerous areas
in the maze. Repeated testing in the EPM provides an index of
memory acquisition and retention because there are experience-
dependent changes in behavior. Studies have shown that exposure
to a second trial causes animals to reduce their open arm explo-
ration [7,8,12,16].  Recently, Galvis-Alonso et al. [10] observed a
reduction in open arm exploration in the second trial when the
interval between sessions was 9 or 33 days, which suggests that
aversion to the open arms is preserved even 33 days after the ﬁrst
maze exposure.
Previous studies on emotional memory performed by our
research group using Trial 1/2 protocol on the EPM revealed
that histamine plays an inhibitory role on emotional memory
[12,36]. Also, other studies concerning the histaminergic system
and memory demonstrated learning and memory impairment
when histamine was  administered [2,15,47]. Nishiga et al. [20]
showed that rats on a histidine-deﬁcient diet exhibited reduced
hippocampal histamine contents and improved eight-arm radial
maze performance. The results of a study by Liu et al. [19], which
used histidine decarboxylase knockout mice, indicated that a lack of
histamine improves fear conditioning consolidation. Furthermore,
according to Alvarez and Banzan [1],  histamine treatment inter-
feres with the consolidation of avoidance responses and impairs
latency and memory efﬁciency.
The microinjection of histamine into the cerebellar vermis
demonstrated that the cerebellar histaminergic system is involved
in the process of consolidation of emotional memory. Several lines
of evidence support the involvement of the cerebellar vermis in
emotional learning [32]. Moreover, studies have evaluated the role
of the cerebellum in emotional memory consolidation, provided
important information about the role of the cerebellum in memory
and explained how neural circuits are related to aversive memories.
Sacchetti et al. [33] demonstrated that cerebellar vermis blockade
caused amnesia when performed immediately after the recall of
fear memories and that the combined inactivation of the cerebel-
lum and amygdala elicited amnesia of strong fear behavior. Thus,
according to the authors, the cerebellum inﬂuences long-term emo-
tional memories, and due to the strong learning, the cerebellum
acquires a durable fear representation, which is sufﬁcient to sup-
port memory processes even in the absence of sites that are crucial
for emotion, such as the amygdala.
It has been previously proposed that the amygdala and cere-
bellum are functionally interconnected during aversive learning
mice in Trials 1 and 2 in the EPM.
HA 1.36 HA 2.72 HA 4.07
 6.0 ± 1.2 7.7 ± 0.8 9.6 ± 1.2
* 53.6 ± 12.9* 86.9 ± 13.2 86.2 ± 7.5
 10.1 ± 1.1 11.1 ± 1.5 10.7 ± 1.1
.1* 163.9 ± 21.4* 134.3 ± 14.5* 125.3 ± 12.8*
* 54.7 ± 7.1* 44.8 ± 4.8*# 41.8 ± 4.3*#
* 82.5 ± 17.5* 78.8 ± 10.5* 88.4 ± 9.6*
 7.0 ± 0.9 9.1 ± 1.4 8.5 ± 1.6
* 2.0 ± 1.1* 1.7 ± 0.5* 1.8 ± 0.9*
 0.5 ± 0.5 0.0 ± 0.0 0.0 ± 0.0
d immediately after Trial 1); HA (histamine microinjected immediately after Trial
 arm entries); OAT (time spent in the open arms); EAE (number of enclosed arm
ms); CT (central platform time); SAP (frequency of stretched-attend postures), HD
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17,40].  According to Sacchetti et al. [34], the vermis and amyg-
ala may  interact, and the vermal electrical stimulation modulates
mygdala activity. These effects are mediated by both direct and
ndirect anatomical connections between the cerebellum and lim-
ic areas as well as through the paleocerebellar projections to
scending catecholamine neurons of the locus coeruleus, the ven-
ral tegmental area and the periaqueductal gray [34]. Therefore, the
resent results may  be due to the effect of histamine on one of these
erebellar projections.
In conclusion, the results indicate that there is a dose-dependent
nhibition of memory when histamine is injected into the cerebellar
ermis. Therefore, it can be suggested that histamine in the cere-
ellum impairs the consolidation of emotional memory in mice.
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